Genetic Testing

EGL Genetic Diagnostics, LLC, provides high-complexity molecular, biochemical and cytogenetic testing for rare and common genetic diseases and disorders.  Founded in 1970, EGL was the first academic laboratory to bring Next Generation Sequencing (NGS) technologies to the commercial clinic market and remains a leader in cutting-edge genetic tests, with “first-to-market” tests comprising more than 80% of its analytical portfolio.  EGL has the largest NGS panels in the industry, and conducts over 35,000 tests annually for genetic diseases, carrier screening, and prenatal testing.  EGL also leads the industry in gene panels, including cancer testing and exome sequencing, to aid diagnosis, prognosis, management and targeted drug therapy (e.g., personalized medicine), and expanded carrier testing capabilities.